Who are Zoster Vaccine Live's main competitors?

Direct comparators (same drug class / molecular target / therapeutic area): Live attenuated influenza vaccine, Stamaril, Sanofi Pasteur, MMR vaccination, mOPV type 2, bOPV, varicella-6.

How often does this brief refresh?

Every 30 minutes from primary sources (FDA, EMA, MHRA, PMDA, ClinicalTrials.gov, USPTO). Subscribe to the RSS feed below for push alerts.

How do I get this as a recurring report?

Subscribe to /feed/ci/zoster-vaccine-live.xml in any RSS reader (Feedly, Inoreader, NewsBlur). Every regulatory action, trial readout, or patent event lands in your feed automatically.

Last reviewed 2026-05-16 · How we verify

Zoster Vaccine Live — Competitive Intelligence Brief

Zoster Vaccine Live (Zoster Vaccine Live) competitive landscape: 6 comparators, recent regulatory actions, upcoming PDUFA, patent timeline. Class: Live attenuated vaccine. Area: Immunology / Infectious Disease.

marketed Live attenuated vaccine Varicella-zoster virus (VZV) Immunology / Infectious Disease Biologic Live · refreshed every 30 min

Target snapshot

Zoster Vaccine Live (Zoster Vaccine Live) — Merck Sharp & Dohme LLC. This live attenuated varicella-zoster virus vaccine stimulates the immune system to recognize and prevent herpes zoster (shingles) by boosting cell-mediated immunity against VZV.

Comparator set (6 drugs)

Auto-detected by same drug class / molecular target / therapeutic area, ranked by phase + recency. Override with ?vs=slug1,slug2,….

Drug	Generic	Sponsor	Phase	Class	Target
Zoster Vaccine Live TARGET	Zoster Vaccine Live	Merck Sharp & Dohme LLC	marketed	Live attenuated vaccine	Varicella-zoster virus (VZV)
Live attenuated influenza vaccine	Live attenuated influenza vaccine	The University of Hong Kong	marketed	Live attenuated vaccine
Stamaril, Sanofi Pasteur	Stamaril, Sanofi Pasteur	Epicentre	marketed	Live attenuated vaccine	Yellow fever virus (17D strain)
MMR vaccination	MMR vaccination	Klara M. Pósfay Barbe	marketed	Live attenuated vaccine
mOPV type 2	mOPV type 2	University of Chile	marketed	Live attenuated vaccine	Poliovirus type 2
bOPV	bOPV	Aga Khan University	marketed	Live attenuated vaccine	Poliovirus serotypes 1 and 3
varicella-6	varicella-6	Beijing Center for Disease Control and Prevention	marketed	Live attenuated vaccine	Varicella-zoster virus

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this set.

Patent timeline (forward window)

No upcoming patent expiries for this set.

Sponsor landscape (Live attenuated vaccine class)

GlaxoSmithKline · 19 drugs in this class
Merck Sharp & Dohme LLC · 11 drugs in this class
Sanofi Pasteur, a Sanofi Company · 9 drugs in this class
PATH · 5 drugs in this class
Sanofi · 5 drugs in this class
Bandim Health Project · 5 drugs in this class
Centers for Disease Control and Prevention · 3 drugs in this class
International Centre for Diarrhoeal Disease Research, Bangladesh · 3 drugs in this class
Beijing Center for Disease Control and Prevention · 2 drugs in this class
Aga Khan University · 2 drugs in this class

Subscribe to ongoing alerts

Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:

Cite this brief

Drug Landscape (2026). Zoster Vaccine Live — Competitive Intelligence Brief. https://druglandscape.com/ci/zoster-vaccine-live. Accessed 2026-05-16.

Build your own brief

Pick any drug + add comparators:

https://druglandscape.com/ci/{slug} — auto-detected competitors
https://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3 — explicit comparators
Brand names auto-resolve: /ci/keytruda → 301 → /ci/pembrolizumab